The largest database of trusted experimental protocols

6 protocols using il 13

1

Cultivation and Stimulation of Human Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human-derived fibroblasts from healthy and asthma subjects were maintained in DMEM medium supplemented with 2 μg/mL of insulin, 1 mM of sodium pyruvate, 1 mM of nonessential amino acids, 4 mM of glutamine, 10% fetal calf serum, and antibiotics (penicillin/streptomycin) at 37°C and 5% CO2. Cells were seeded at 0.5 − 1 × 105 cells/mL in 25 cm2 flasks. At ~70% confluency, cells were stimulated with 20 ng/ml of IL-13 (ProSpec). Control cell cultures were either left untreated or treated with equal volumes of DMSO as vehicle.
+ Open protocol
+ Expand
2

Dendritic Cell Cytokine Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human cytokines used for DC treatments were as follows: LT-α (TNF-β), GM-CSF, M-CSF, IL-1β, IL-6, IL-4, TNF-α, IL-13, IFN-γ, IL-10 (ProSpec-Tany Technogene, Rehovot, Israel) and TGF-β1 (R&D Systems, Minneapolis, Minnesota, USA) were used in culture within a final concentration range of 5–80 ng/ml. Dexamethasone was used at a final concentration in culture at 30 ng/ml (Sigma-Aldrich, St. Louis, MO). All cell culture experiments utilized RPMI 1640 tissue culture medium, heat-inactivated (56°C/20 min) fetal calf serum (FCS), penicillin/streptomycin and L-glutamine (SAFC Biosciences, Lenexa, KS).
+ Open protocol
+ Expand
3

Differentiation of Macrophage Subtypes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant granulocyte-macrophage colony stimulating factor (GM-CSF), macrophage (M)-CSF, interleukin (IL)-1β, IL-6, IL-4, IL-10, IL-13, interferon (IFN)-γ, lymphotoxin (LT)-α, tumor necrosis factor (TNF), M-CSF and GM-CSF were purchased from ProSpec-Tany Technogene (Rehovot, Israel), transforming growth factor (TGF)-β1 from R&D Systems (Minneapolis, MN), and dexamethasone was purchased from Sigma-Aldrich (St. Louis, MO). A mouse monoclonal antibody (clone 3C9) that recognizes the IgV domain of human CRIg was kindly provided by Dr. Menno van Lookeren Campagne (Genentech, San Francisco, CA). RPMI 1640 tissue culture medium, foetal calf serum (FCS) and L-glutamine were purchased from SAFC Biosciences (Lenexa, KS).
+ Open protocol
+ Expand
4

Macrophage Polarization by Cancer Cell EVs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human primary CD14+ monocytes were isolated from a buffy coat and tested for purity using flow cytometry. Monocytes were seeded at a density of 20 × 104 in a 24-well plate. The culture medium was advance RPMI-1640 (Gibco) supplied with 10% FBS, 1% L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, and 250 ng/ml fungizone. The cells were allowed to adhere for 90 min, and unattached cells were then washed away with PBS and the wells were supplied with fresh media plus 100 ng/ml M-CSF (R&D Systems, Minneapolis, MN, USA). Monocytes were allowed to differentiate into macrophages for seven days, and images were taken each day using a Nikon DS-Fi2 camera (Nikon, Tokyo, Japan).
To study the effect of cancer cell EVs on macrophage polarization, differentiated macrophages were then subjected to EVs isolated from HSC-3 and SCC-25 cells for 24 hours. As a positive control, macrophages were differentiated to M1 macrophages using 10 ng/ml LPS (Sigma-Aldrich) and 20 ng/ml IFN-γ (Prospec, Rehovot, Israel), and to M2 macrophages using 20 ng/ml IL-4 and 20 ng/ml IL-13 (Prospec).
To check macrophage phenotypes using q-PCR, cells were lysed using an RLT buffer (Qiagen, Düsseldorf, Germany) and kept at −80°C until RNA isolation.
+ Open protocol
+ Expand
5

Isolation and Culture of Murine Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMDMs were isolated from 6 to 8-week-old BABL/c male mice as described (Davis, 2013 (link)). Primary cells were maintained on bacterial grade plates for 1 week in DMEM (Hyclone), supplemented with 10% fetal bovine serum (Hyclone), 2 mM L-glutamine, 100 units/mL penicillin G, 100 mg/mL streptomycin (Invitrogen) and 5 ng/mL M-CSF (ProSpec). Adherent cells were then replated on plastic tissue culture plates in fresh media and used 24 h after replating. The immortalized rat Kupffer cell line (purchased from Applied Biological Materials Inc.) was maintained in the same media as BMDMs but without M-CSF.
For stimulation, BMDMs or the Kupffer cell line were exposed to recombinant IFN-γ, IL-10, IL-4 or IL-13 (ProSpec) after starvation overnight in 0.5% fetal bovine serum (Hyclone), and harvested at the appropriate time points.
For transfection, 40 nM miRNA mimics, inhibitors or negative control (GenePharma, China) was transfected using the Lipofectamine 2000 Transfection Reagent (Life technologies) according to the manufacturer's instructions.
+ Open protocol
+ Expand
6

Macrophage Differentiation and Polarization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human THP-1 and HEK293T cell lines were obtained from the iCell Bioscience Inc. (Shanghai, China). THP-1 cells were cultured in RPMI-1640 medium (Gibco, MD, USA) supplemented with 15% fetal bovine serum (FBS, Gibco, MD, USA), 1% penicillin/streptomycin solution (Gibco, MD, USA) and 50 μM β-Mercaptoethanol (Solarbio, Beijing, China) in a humidified cell incubator with 5% CO2 at 37°C. 293T cells were grown in Dulbecco’s modified Eagle’s medium with high glucose (DMEM, Gibco, MD, USA) with 10% FBS and 1% penicillin/streptomycin. For M0 macrophage differentiation, THP-1 cells were treated with 50 ng/mL phorbol 12-myristate 13-acetate (PMA, Solarbio, Beijing, China) for 24 h. For M1 polarization, THP1-derived M0 macrophages were then treated with 20 ng/mL IFNγ (Prospec, NZ, Israel) and 100 ng/mL lipopolysaccharides (LPS, Solarbio, Beijing, China) for another 48 h. For M2 polarization, THP1-derived M0 macrophages were treated with 20 ng/mL IL4 and 5 ng/mL IL13 (Prospec, NZ, Israel) for 48 h.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!